Testing effectiveness (Phase 2)Study completedNCT03286556
What this trial is testing
Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Who this might be right for
Idiopathic Pulmonary Fibrosis, Acute Fatal Form
University of Alabama at Birmingham 51